Search hospitals

>

North Carolina

>

Greenville

East Carolina University

Claim this profile

Greenville, North Carolina 27834

Global Leader in Cancer

Global Leader in Sickle Cell Disease

Conducts research for Brain Tumor

Conducts research for Breast Cancer

Conducts research for Lung Cancer

327 reported clinical trials

26 medical researchers

Photo of East Carolina University in GreenvillePhoto of East Carolina University in Greenville

Summary

East Carolina University is a medical facility located in Greenville, North Carolina. This center is recognized for care of Cancer, Sickle Cell Disease, Brain Tumor, Breast Cancer, Lung Cancer and other specialties. East Carolina University is involved with conducting 327 clinical trials across 704 conditions. There are 26 research doctors associated with this hospital, such as Andrea R. Whitfield, Darla Liles, MD, Frank A. Vicini, and Mahvish Muzaffar.

Area of expertise

1

Cancer

Global Leader

East Carolina University has run 26 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage I
Stage II
2

Sickle Cell Disease

Global Leader

East Carolina University has run 21 trials for Sickle Cell Disease. Some of their research focus areas include:

HbSS positive
HbSβ0 positive
HbSβ0-thalassemia positive

Top PIs

Clinical Trials running at East Carolina University

Ovarian Cancer

Breast Cancer

Cancer

Multiple Myeloma

Melanoma

Testicular cancer

Brain Tumor

Esophageal cancer

Cutaneous Melanoma

Neuroblastoma

Image of trial facility.

Olvi-Vec + Chemotherapy

for Ovarian Cancer

The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemotherapy and bevacizumab compared to the Active Comparator Arm with Physician's Choice of chemotherapy and bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and primary peritoneal cancer). This Phase III trial builds on the efficacy and safety data reported in the previous Phase II VIRO-15 trial with promising objective response rate and progression-free survival observed in heavily pre-treated patients with platinum-resistant/refractory ovarian cancer. The phase II results also showed that the intra-peritoneal route of delivery was efficient in generating tumor cell killing and immune activation, and led to clinical reversal of platinum-resistance or refractoriness in this difficult-to-treat patient population.

Recruiting

2 awards

Phase 3

7 criteria

Image of trial facility.

Biobank Collection

for Cancer

This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal study. This means it collects and stores samples and information over time, throughout the course of a patient's cancer treatment. By looking at samples and information collected from the same people over time, researchers hope to better understand how cancer changes over time and over the course of medical treatments.

Recruiting

1 award

N/A

10 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at East Carolina University?

Where is East Carolina University located?

Who should I call to ask about financial aid or insurance network?

What insurance does East Carolina University accept?

What awards or recognition has East Carolina University received?